Ilya Mechnikov and Paul Ehrlich: The Pioneers Who Discovered the Two Sides of the Immune System (1908)

Nobel Information Card

• Award Year: 1908
• Field: Physiology or Medicine
• Award Rationale: In recognition of their work on immunity.
• Ilya Mechnikov - Born: 15 May 1845, Ivanovka, Ukraine (Russian Empire)
• Ilya Mechnikov - Died: 15 July 1916, Paris, France
• Paul Ehrlich - Born: 14 March 1854, Strehlen, Silesia (present-day Poland)
• Paul Ehrlich - Died: 20 August 1915, Bad Homburg, Germany
• Nationality: Russian (Mechnikov), German (Ehrlich)
• Institution: Pasteur Institute, Paris (Mechnikov); Institute of Experimental Therapy, Frankfurt (Ehrlich)

Life and Education

Ilya Ilyich Mechnikov

Ilya Ilyich Mechnikov was born on 15 May 1845 in the village of Ivanovka, in the Ukrainian territories of the Russian Empire. His father, Ilya Ivanovich Mechnikov, was a landowner who had served as an officer in the Imperial Guard. His mother, Emilia Lvovna Nevakhovich, came from an enlightened Jewish family and played a decisive role in young Mechnikov's intellectual development. The youngest of five children, Mechnikov showed an extraordinary curiosity for the natural sciences from an early age.

Mechnikov distinguished himself as a brilliant student at the gymnasium in Kharkov. While still only sixteen years old, he wrote to the publisher of a scientific journal to report his observations on a species of protozoan. He began his studies in the natural sciences at Kharkov University and completed the four-year program in only two years, graduating in 1864. He pursued advanced studies at the universities of Giessen, Göttingen, and Munich in Germany, where he worked with leading zoologists of the period such as Rudolf Leuckart and Carl Theodor von Siebold.

After receiving his doctorate from St. Petersburg University in 1867, he took up a position as professor of zoology at Odessa University. During this period, he conducted intensive research in comparative embryology and made important contributions to the developmental biology of invertebrates. However, Mechnikov's personal life was troubled; his first wife, Ludmila Feodorovitch, died of tuberculosis in 1873, plunging him into a deep depression. In 1875 he married his second wife, Olga Belokopitova; this marriage both restored him emotionally and carried him into the most productive scientific period of his career.

Paul Ehrlich

Paul Ehrlich was born on 14 March 1854 in the town of Strehlen in Silesia (today Strzelin, Poland). His father, Ismar Ehrlich, was a prosperous Jewish merchant who operated a liqueur distillery and served as postmaster. His mother, Rosa Weigert, was a cousin of the renowned pathology professor Carl Weigert. This family connection introduced the young Ehrlich to histology and staining techniques at an early age. His cousin Weigert's work on tissue staining with aniline dyes set the direction of Ehrlich's scientific career.

Ehrlich studied medicine at the universities of Breslau, Strasbourg, Freiburg, and Leipzig. From his student years onward, he developed a fascination with the interaction between chemical dyes and biological tissues. His doctoral thesis examined the tissue affinities of various aniline dyes and laid out the fundamental principle that would guide his entire career: the selective binding of chemical substances to biological structures. In 1878 he received his medical degree from Leipzig.

After graduating, Ehrlich joined Friedrich von Frerichs's clinic at the Charité Hospital in Berlin. There he carried out pioneering work on the staining and classification of blood cells, developing the staining methods that defined the principal leukocyte types — neutrophils, eosinophils, and basophils. This work, which laid the modern foundations of hematology, brought Ehrlich international recognition. In 1888, however, he contracted tuberculosis while working with his own blood preparations and was forced to travel to Egypt for treatment. After recovering, he returned to Berlin and began working in Robert Koch's laboratory.

Scientific Work

Mechnikov and the Theory of Phagocytosis

Mechnikov's greatest contribution to immunology grew out of a series of observations he made in Messina, Italy, in 1882. While studying the transparent tissues of starfish larvae, he inserted a rose thorn into one of the larvae and observed that mobile cells gathered around the thorn and attempted to engulf it. This dramatic moment became the turning point of Mechnikov's scientific life. He realized that the ability of cells to engulf and destroy foreign particles might form the basis of the organism's defense mechanism.

Mechnikov named these engulfing cells phagocytes, from the Greek words phagein (to eat) and kytos (cell), and he called the process phagocytosis. In the following years, Mechnikov studied phagocytosis systematically. In transparent invertebrates such as Daphnia (the water flea), he observed that fungal spores were engulfed and digested by phagocytes. Extending these observations to vertebrates and humans, he demonstrated that blood cells destroy bacteria through phagocytosis.

In 1888, Mechnikov accepted an invitation from Louis Pasteur and joined the Pasteur Institute in Paris. There he carried out extensive experimental work to deepen his theory of phagocytosis. Mechnikov documented in detail how different bacterial species are recognized and destroyed by phagocytes, the relationship between phagocytosis and the inflammatory process, and the role of cellular mechanisms in the immune response. He formulated the cellular theory of immunity, which held that phagocytes play the primary role in defense against infection.

Ehrlich and the Humoral Theory of Immunity

Paul Ehrlich's work in immunity grew out of the principle of the selective binding of chemical dyes to biological structures. Applying this principle to immune mechanisms, Ehrlich developed the side-chain theory (Seitenkettentheorie). According to this theory, various receptors (side chains) were present on the cell surface, and toxins bound to these receptors. Toxin binding stimulated the cell to produce more receptors, and the overproduced receptors were released into the blood and became antitoxins (antibodies).

Ehrlich's side-chain theory offered the first coherent explanation for antibody formation. To support this theory, Ehrlich built upon Emil von Behring's work on the diphtheria antitoxin. He played a critical role in standardizing antitoxin sera; by defining the quantitative relationships between toxin and antitoxin, he made safe dosing of serum therapy possible. The antitoxin unit system that Ehrlich developed was one of the earliest examples of biological standardization.

Ehrlich examined in depth the chemical specificity of the antibody–antigen interaction. He showed that different antigens elicit different antibodies and that the interaction is as specific as a lock and key. By defining the complement system, he demonstrated that antibodies act not alone but together with additional factors in the blood serum. This body of work established the fundamental principles of humoral immunity.

Ehrlich's scientific vision was not limited to immunity. He is also known as the founder of chemotherapy. Developing the concept of the magic bullet (Zauberkugel), he proposed that chemical agents could be designed to selectively target disease-causing pathogens. Salvarsan (arsphenamine), which he developed in 1909 together with Sahachiro Hata, was the first effective chemotherapeutic agent used to treat syphilis and heralded the birth of modern pharmacology.

The Discovery That Led to the Nobel Prize

The 1908 Nobel Prize was awarded in the midst of one of the most fundamental debates in immunology: was the immune response governed primarily by cellular mechanisms or by humoral (fluid-based) factors? While Mechnikov argued that phagocytes played the primary role in fighting infection, Ehrlich and the German school emphasized the protective effects of antibodies and serum. The debate between these two camps was one of the most important intellectual conflicts shaping immunology from the late nineteenth century onward.

Mechnikov presented extensive experimental evidence in defense of the theory of phagocytosis. He documented the cellular response to infection in different animal species. He showed the capacity of macrophages and microphages (neutrophils) to engulf and destroy bacteria. He revealed the central role of phagocytes in pathological processes such as abscess formation, inflammation, and wound healing. His laboratory at the Pasteur Institute became the world's leading center for cellular immunity research.

Ehrlich, for his part, laid the foundations of the chemistry of immunity. He defined the quantitative laws of the antibody–antigen interaction. He classified the different types of antibodies and determined their distinct functions. He described in detail humoral immune mechanisms such as complement fixation, lysis, and agglutination. The Institute of Experimental Therapy in Frankfurt became the center of this work.

The Nobel Committee's decision to divide the prize between the two scientists in fact reflected a deep scientific insight. The immune system was composed neither of purely cellular nor of purely humoral mechanisms; both arms played indispensable roles in defense against infection. Modern immunology has been built on a synthesis of the views of Mechnikov and Ehrlich.

The Prize and Its Aftermath

The 1908 Nobel Prize in Physiology or Medicine was shared between Ilya Mechnikov and Paul Ehrlich for their work on immunity. The two scientists, from different angles, were seeking answers to the same great question: how does an organism resist infection? The shared prize amounted to formal recognition that both approaches were valid.

After the Nobel Prize, Mechnikov continued his work at the Pasteur Institute. In the final years of his career, he gradually shifted from immunological research to the biology of aging. He argued that toxins produced by harmful bacteria in the human intestine accelerate aging, and he became a pioneer of the concept of probiotics. He advocated that fermented dairy products — particularly Bulgarian yogurt — could improve gut flora and extend lifespan. These views can be seen as an early forerunner of today's research into the gut microbiome. Mechnikov died on 15 July 1916 in Paris, at the age of seventy-one.

After his Nobel Prize, Ehrlich concentrated on chemotherapy research. The development of Salvarsan was the last great achievement of his scientific career. By systematically testing hundreds of chemical compounds, he discovered that compound number 606 was effective against syphilis. Before the discovery of antibiotics, Salvarsan was the most important chemotherapeutic agent used against infectious diseases. Ehrlich died of a heart attack in Bad Homburg on 20 August 1915, at the age of sixty-one, shortly after the outbreak of the First World War.

Legacy and Impact Today

The combined legacy of Mechnikov and Ehrlich underpins the integrated understanding of modern immunology. Today it is recognized that the immune system consists of two principal arms: innate and adaptive immunity. Mechnikov's discovery of phagocytosis laid the foundation for innate immunity, while Ehrlich's work on antibodies made possible the understanding of the humoral arm of adaptive immunity.

Mechnikov's concept of phagocytosis is the cornerstone of innate immunity research. Macrophages, neutrophils, and dendritic cells form the first line of defense against infection. The 2011 Nobel Prize in Physiology or Medicine, awarded for work on innate immunity, showed that the scientific tradition Mechnikov began over a century earlier remains alive. As the pioneer of the probiotic concept, Mechnikov's early intuitions about the gut microbiome have grown into a major field of research today.

Ehrlich's side-chain theory provided the conceptual framework for modern receptor biology and pharmacology. The concept of receptor–ligand interaction underpins drug design. Ehrlich's magic-bullet vision is the inspiration behind targeted therapies, monoclonal antibody treatments, and cancer immunotherapy. Today, monoclonal antibody drugs such as trastuzumab (Herceptin), rituximab, and nivolumab are concrete realizations of the selective therapeutic approach Ehrlich envisioned a century ago.

The COVID-19 pandemic once again highlighted the importance of both the cellular and the humoral arms of the immune system. The ability of mRNA vaccines to elicit both an antibody response and a T-cell response illustrated just how vital it is for the two arms of immunity represented by Mechnikov and Ehrlich to work together.

Lesser-Known Facts

• Mechnikov discovered the idea of phagocytosis through an experiment with a rose thorn. According to a family account, while his children were decorating the Christmas tree, Mechnikov pushed a rose thorn into a starfish larva and made his historic observation.
• Mechnikov attempted suicide twice during his life: first by taking morphine after the death of his first wife, and a second time by deliberately infecting himself with relapsing fever. He survived both attempts.
• Ehrlich smoked cigars constantly in his laboratory, reportedly consuming up to twenty-five a day. He was forever scribbling notes and diagrams in the margins of his laboratory notebooks; these annotations later became invaluable sources for historians of science.
• Mechnikov's conviction in the probiotic concept was so strong that he consumed fermented dairy products daily, and he helped popularize the habit across the Europe of his time.
• Ehrlich's development of Salvarsan represented the first major success of systematic screening in drug research. Arriving at an effective formula only after testing 606 compounds, he became a pioneer of the modern drug-discovery process.
• Despite their scientific disagreements, Mechnikov and Ehrlich held each other in personal regard. Both expressed satisfaction at sharing the Nobel Prize.
• Ehrlich's staining techniques laid the foundations of hematology. Today's methods of blood-cell counting and leukocyte differentiation trace their origins to Ehrlich's work in the 1870s.